Brian Nowosielski

Pharmacy staff's confidence in the Senior Safe's effectiveness was the key factor leading to the success of managing OTC medication misuse among older adults.

US adults were surveyed about their understanding of shared clinical decision-making following the HHS overhaul of childhood vaccines.

Episode 6 explores what pharmacists in the diabetes space need to know about outcomes data, safety, and when to escalate LDL-lowering therapy.

In part 3 of our interview with Susan Thomas, RN, she focused on the pharmacist’s role in her organization’s creation of a newly launched women’s health benefit program.

The administration announces back-to-back approvals for oral therapies used to treat uncomplicated urogenital gonorrhea.

Susan Thomas, RN, CCO at LucyRx, explained the unique offerings from a newly introduced women’s health benefit program launched on January 1, 2026.

Although several vaccines are still being recommended, a variety of those protecting against respiratory viruses and other diseases have been narrowed on child vaccine schedules.

The company announces that the pill is now available at over 70,000 pharmacies across the country.

Susan Thomas, RN, joined Drug Topics to discuss current gaps in women’s health and how pharmacists are stepping in to counsel in this space more than ever before.

As social media’s growth seemingly has no end in sight, pharmacists must be conscious of its potential risks and benefits when using these platforms for either personal or professional use.

In part 3 of our interview, Jennifer Flynn, CPHRM, flips the script on potential harms in using social media and explores how pharmacists can use it to advance their career.

As patients with diabetes and other cardiometabolic conditions take control of their insulin regimens, so too are pharmacists stepping in to help manage new technologies, guidelines, and medications.

Jennifer Flynn, CPHRM, joins Drug Topics to discuss the nuances in social media use for pharmacists and the potential risks they can encounter.

In this episode, host Taylor Watterson, PharmD, PhD, welcomes Julissa Gomez, a fourth-year pharmacy student at the University of Illinois Chicago Retzky College of Pharmacy.

Spanning those focused on pneumococcal diseases to continued developments of vaccines against COVID-19, these are the most-read immunization stories from 2025.

Jennifer Flynn, CPHRM, vice president of health care risk management at the Healthcare Provider Service Organization, discusses pharmacists’ roles in patient privacy.

With brand-new challenges and opportunities in the GLP-1 space and obesity management as a whole, here are the top developments from the past year.

Marking 5 years since the COVID-19 pandemic forever changed health care in 2020, check out the top 5 COVID-19 stories from 2025.

A recent study reveals COVID-19 vaccination significantly reduces severe maternal disease and preterm birth risks during pregnancy.

In a recap of his recent NPhA continuing pharmacy education presentation, Kenric B. Ware, PharmD, MBA, AAHIVP, discussed pharmacists’ role in addressing HIV stigma.

In part 3 of our interview with Kenric B. Ware, PharmD, MBA, AAHIVP, he discusses the best approaches for addressing HIV care and prevention stigma.

The landmark oral formulation of the popular weight loss drug is set to launch in early 2026.

Kenric B. Ware, PharmD, MBA, AAHIVP, addresses the pharmacist’s role in addressing HIV stigma and providing public health services for patients with the virus.

Kenric B. Ware, PharmD, MBA, AAHIVP, presents persistently common stigmas in HIV care and prevention from a recent NPhA webinar.

With little evidence on vaccine coverage for people living with HIV, researchers explored pneumococcal vaccine rates between 2014 and 2023.

This December 2025 order is an extension of HHS’ recommendation to reconsider marijuana as a Schedule III medication in 2023.

During his second term, President Trump has bolstered his approach at lowering prescription drug prices in the US through innovative yet unprecedented decisions.

Among patients previously reporting COVID-19, researchers conduct a case-control study of REM-predominant obstructive sleep apnea.

In this episode, Natalie DiPietro Mager, PharmD, PhD, MPH, meets with Karen Kier, PhD, RPh, BCPS, BCACP, to discuss warning labels for hormonal replacement therapy.

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discussed potential safety concerns and the pharmacist’s role in managing insulin.